Document Preview Unavailable

Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: a mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes

Cavo Alessia; Rubagotti Alessandra; Zanardi, Elisa; Fabbroni Chiara; Zinoli Linda; et al.  Therapeutic Advances in Medical Oncology Vol. 10,  (Jan 2018).

You might have access to this document